Medical News

RSS

New head lice treatment receives FDA approval

The treatment, Xeglyze, was developed by Hatchtech, an Australian pharmaceutical company and will be commercialized by Dr Reddy's Laboratories.

3 Aug 2020

Routine health checkups at 18 months can effectively predict autism spectrum disorder

An early diagnosis of autism spectrum disorder, a type of developmental disorder was found to be effective from routine health checkups of infants at 18 months of age.

3 Aug 2020

Cloth face masks have potential to reduce the transmission of SARS-CoV-2 viruses

A literature review coordinated by Karolinska Institutet in Sweden and McMaster University in Canada demonstrates that cloth face masks provide clinically useful levels of filtration, which has the potential to reduce the spread of viruses such as SARS-CoV-2.

3 Aug 2020

Children exposed to trauma show biological signs of aging faster

Children who suffer trauma from abuse or violence early in life show biological signs of aging faster than children who have never experienced adversity, according to research published by the American Psychological Association.

3 Aug 2020

Oxford Nanopore Technologies partners with UK Government to roll out LamPORE, a new generation of COVID-19 test

Oxford Nanopore today announces an agreement with the UK’s Department of Health and Social Care, to roll out its novel LamPORE test.

From Oxford Nanopore Technologies 3 Aug 2020

Maternal vaccination could protect infants against RSV illness

Immunizing pregnant women with a potential vaccine against RSV could prevent the most common cause of pneumonia in their babies.

3 Aug 2020

Photonics-based device could help COVID-19 patients with adequate treatments

Few could have foreseen the considerable impact that SARS-CoV-2 has had so far and is still having worldwide. Numbers continue to escalate and the complexity of the COVID-19 symptoms have hindered all efforts to optimize its treatment.

3 Aug 2020

Researchers identify transferrin as potential contributor to COVID-19 severity

SARS-CoV-2 is the coronavirus that causes COVID-19. It is currently not known why some individuals develop only mild or no symptoms when infected, whilst others experience severe, life-threatening forms of the disease.

3 Aug 2020

Immune system's oldest branches may underpin COVID severity

One of the immune system's oldest branches, called complement, may be influencing the severity of COVID disease, according to a new study from researchers at Columbia University Irving Medical Center.

3 Aug 2020

Hospital merger in Washington state stokes fears about Catholic limits on care

The proposed merger of a well-regarded secular hospital system and a larger Roman Catholic system in Washington state has triggered new alarms about religious restrictions on patients' access to care.

3 Aug 2020

American baby boomers have lower cognition scores than earlier generations

In a reversal of trends, American baby boomers scored lower on a test of cognitive functioning than did members of previous generations, according to a new nationwide study.

3 Aug 2020

Smartphone alert can aid laypersons in opioid overdose reversal

Without timely reversal, opioid overdose causes respiratory depression that may deteriorate into apnea, leading to brain injury and even death.

3 Aug 2020

What seniors can expect as their new normal in a post-vaccine world

Imagine this scenario, perhaps a year or two in the future: An effective COVID-19 vaccine is routinely available and the world is moving forward. Life, however, will likely never be the same — particularly for people over 60.

3 Aug 2020

Screening for pancreatic cancer using artificial intelligence

Dr. Ananya Malhotra speaks to News-Medical about her research into how pancreatic cancer prognosis could be improved by using artificial intelligence.

3 Aug 2020

Meningitis case at Children's National Hospital raises concerns about antibiotic resistance

A recent meningitis case at Children's National Hospital raises serious concerns about antibiotic resistance in the common bacterium that caused it, researchers from the hospital write in a case report.

3 Aug 2020

Stabilized prefusion spike vaccine candidate induces powerful immune response

A new research paper by scientists at Janssen Vaccines & Prevention BV, in the Netherlands and published on the preprint server bioRxiv* is based on the assumption that an effective vaccine against these infections will induce neutralizing antibodies and an immune response favoring Th1 immunity.

3 Aug 2020

Dexamethasone should be a standard drug in severe COVID-19

Many scientists have explored the use of new as well as already approved drugs for this condition, and one of the very few promising leads is dexamethasone. Dexamethasone is a corticosteroid, which has been reported in some earlier studies to reduce mortality in these patients by 18% and 36% in COVID-19 patients who are on oxygen and ventilators, respectively.

3 Aug 2020

Americans are adjusting their use of social media platforms amid COVID-19 pandemic

As national tensions rise, a new national survey of 2,000 people commissioned by The Ohio State University Wexner Medical Center finds more Americans are adjusting how they use social media platforms.

3 Aug 2020

SARS-CoV-2 spike protein recognized by innate immune receptors in a glycan-dependent way

The spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) depends on its ability to infect new host cells following its replication and release from infected cells. This pivots on its ability to bind to cell surface receptors like the ACE2 enzyme.

3 Aug 2020

Severe fatigue common in COVID-19, independent of disease severity

Patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection often complain of fatigue, but now a new study shows that it also causes severe and frequent fatigue in those who recover after mild illness too.

2 Aug 2020